Skip to main content
. 2022 Oct 4;34(1):145–159. doi: 10.1681/ASN.2022040454

Figure 4.


Figure 4.

BK viremia occurred more frequently in the IFX-treated subjects. Number of patients at risk is presented at selected days after transplant and includes all patients who received IFX (n=114, red) or PLBO (n=112, blue) infusion. Patients are censored at day of last follow-up. P value results from log-rank test comparing the treatment groups. BK viremia defined as BK virus infection requiring a change in immunosuppression or antiviral therapy.